In a wide-ranging discussion on the future of genomics and cancer diagnostics in India, senior leaders from Strand Life ...
Selected U.S. Privacy & Cyber Updates - SEC Dismisses Remaining Claims Against SolarWinds - On November 20, 2025, the Securities and ...
Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.
This study provides useful insights into addressing the question of whether the prevalence of autoimmune disease could be driven by sex differences in the T cell receptor (TCR) repertoire, correlating ...
The problem, Zaaijer explained, is that algorithms used in precision medicine models overwhelming are built on DNA with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback